ACS CAN 2022 Montana Virtual Policy Briefing: Biomarker Testing - The Key to Precision Medicine

Biomarker testing is growing increasingly important in cancer care, allowing doctors to better understand and tailor treatment to an individual patient’s unique disease. Timely access to appropriate biomarker testing can help achieve better health outcomes, improve quality of life and reduce costs by connecting patients to the most effective treatment for their cancer. Join ACS CAN for a virtual briefing about precision medicine and the importance of expanding access to this testing so that patients across Montana can benefit from the latest advances in treatment.

Please complete the registration information below: